These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3761959)

  • 1. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Flury H; Tournoux A; Martenet AC
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE; Becker H; Fuchs HB
    Klin Monbl Augenheilkd; 1988 Mar; 192(3):248-51. PubMed ID: 3374015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
    Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
    Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
    Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
    Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group.
    Stewart WC; Cohen JS; Netland PA; Weiss H; Nussbaum LL
    Am J Ophthalmol; 1997 Oct; 124(4):498-505. PubMed ID: 9323940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
    Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
    Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.
    Stewart WC; Shields MB; Allen RC; Lewis RA; Cohen JS; Hoskins HD; Hetherington JN; Bahr RL; Noblin JE; Delehanty JT
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):258-61. PubMed ID: 1869063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system and plasma lipid profiles associated with carteolol and timolol in postmenopausal black women.
    Bartlett JD; Olivier M; Richardson T; Whitaker R; Pensyl D; Wilson MR
    J Glaucoma; 1999 Dec; 8(6):388-95. PubMed ID: 10604299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with timolol in treatment of glaucoma (author's transl)].
    Bischoff P
    Klin Monbl Augenheilkd; 1978 Aug; 173(2):202-7. PubMed ID: 359904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension].
    Coulangeon LM; Sole M; Menerath JM; Sole P
    Ophtalmologie; 1990; 4(2):156-61. PubMed ID: 2235007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T; Kitazawa Y; Noma A; Maeda S; Kato A; Ando Y; Ido T; Inazumi K; Hayakawa T; Goto Y; Ichien M
    J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1% carteolol hydrochloride eyedrops: long-term experience in the treatment of chronic open-angle glaucoma].
    van Husen H
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):491-5. PubMed ID: 3550260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
    Stryz JR; Merté HJ
    Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G; Randazzo S; Spina F
    Ophtalmologie; 1988; 2(5):431-3. PubMed ID: 3244464
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
    Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
    Arzneimittelforschung; 2006; 56(12):820-5. PubMed ID: 17260669
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].
    Allaire C; Trinquand C; Nordmann JP; Dascotte JC; George JL; Lesure P; Rouland JF; Khaitrine L; Sirbat D
    J Fr Ophtalmol; 1995; 18(1):22-6. PubMed ID: 7738291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.